Evidence map›Paper›PMID 18723894›Full record

ArticleGenetics2008

Rtf1-mediated eukaryotic site-specific replication termination.

T Eydmann, E Sommariva, T Inagawa, S Mian, A J S Klar, J Z Dalgaard

Abstract read
In one paragraph

Article in Genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. eLife · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Timeless protection of telomeres.Current genetics · 2016
    Review
  6. Phosphorylation of CMG helicase and Tof1 is required for programmed fork arrest.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  7. Functional architecture of the Reb1-Ter complex of Schizosaccharomyces pombe.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

T EydmannMarie Curie Research Institute, The Chart, Oxted RH8 0TL, United Kingdom.
E Sommariva
T Inagawa
S Mian
A J S Klar
J Z Dalgaard

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

The molecular mechanisms mediating eukaryotic replication termination and pausing remain largely unknown. Here we present the molecular characterization of Rtf1 that mediates site-specific replication termination at the polar Schizosaccharomyces pombe barrier RTS1. We show that Rtf1 possesses two chimeric myb/SANT domains: one is able to interact with the repeated motifs encoded by the RTS1 element as well as the elements enhancer region, while the other shows only a weak DNA binding activity. In addition we show that the C-terminal tail of Rtf1 mediates self-interaction, and deletion of this tail has a dominant phenotype. Finally, we identify a point mutation in Rtf1 domain I that converts the RTS1 element into a replication barrier of the opposite polarity. Together our data establish that multiple protein DNA and protein-protein interactions between Rtf1 molecules and both the repeated motifs and the enhancer region of RTS1 are required for site-specific termination at the RTS1 element.

Indexed as

DNA ReplicationEnhancer Elements, GeneticAmino Acid MotifsAmino Acid SequenceDNADNA, RibosomalFungal ProteinsModels, GeneticMolecular Sequence DataPoint MutationProtein Structure, TertiarySaccharomyces cerevisiae ProteinsSchizosaccharomycesSequence Homology, Amino AcidTATA-Box Binding ProteinTwo-Hybrid System TechniquesDNADNA, RibosomalFungal ProteinsRTF1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTATA-Box Binding Protein

Identifiers

PMID18723894
PMCPMC2535681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.